new video loaded: F.D.A. Panel Endorses Pfizer-BioNTech Shots for Young Children
transcript
transcript
F.D.A. Panel Endorses Pfizer-BioNTech Shots for Young Children
A Food and Drug Administration advisory committee voted to recommend a pediatric dose of the Pfizer-BioNTech coronavirus vaccine for children between the ages of 5 and 11.
-
“Based on the totality of scientific evidence available, do the benefits of the Pfizer-BioNTech Covid-19 vaccine when administered as a two-dose series, 10 micrograms each dose three weeks apart, outweigh its risks for use in children 5 to 11 years of age?” “This concludes the vote. Out of 18 voting members, 17 voted yes and we had one abstain.”
Recent episodes in Latest Video
Whether it’s reporting on conflicts abroad and political divisions at home, or covering the latest style trends and scientific developments, Times Video journalists provide a revealing and unforgettable view of the world.
Whether it’s reporting on conflicts abroad and political divisions at home, or covering the latest style trends and scientific developments, Times Video journalists provide a revealing and unforgettable view of the world.
Source link
